CeriBell, Inc. (CBLL) vs PROCEPT BioRobotics Corporation (PRCT)
CeriBell, Inc. and PROCEPT BioRobotics Corporation are both Medical Devices companies. PROCEPT BioRobotics Corporation is the larger, with a market value of $1.0B against $914.2M — 1.1× the size. CeriBell, Inc. grew revenue faster over the last twelve months: 31.7% against 22.7%. PROCEPT BioRobotics Corporation has the higher net margin (−32.5% vs −64.7%) and the higher return on invested capital (−43.6% vs −229.8%). Across the 17 metrics below, PROCEPT BioRobotics Corporation leads on 10 and CeriBell, Inc. on 7.
Valuation
Profitability
| Metric | CBLL | PRCT | Medical Devices median |
|---|---|---|---|
| Gross margin | 88.90% | 64.22% | 56.01% |
| Operating margin | (68.62%) | (33.86%) | (15.03%) |
| Net margin | (64.73%) | (32.54%) | (20.40%) |
| Free cash flow margin | (55.02%) | (25.17%) | (7.24%) |
| Return on equity | (43.93%) | (30.24%) | (15.32%) |
| Return on assets | (35.29%) | (22.12%) | (19.72%) |
| Return on invested capital | (229.76%) | (43.57%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack